First Report of the Prevalence of Human T-Lymphotropic Virus Type 1 (HTLV-1) for Hemodialysis Patients in Tehran

被引:3
|
作者
Yazdani, Reza [1 ]
Dadmanesh, Maryam [2 ]
Ghorban, Khodayar [3 ]
机构
[1] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Pediat Ctr Excellence, Childrens Med Ctr, Tehran, Iran
[2] AJA Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[3] AJA Univ Med Sci, Sch Med, Dept Infect Dis, Tehran, Iran
来源
关键词
HTLV-1; Hemodialysis; Military Hospitals; Prevalence;
D O I
10.5812/archcid.65512
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Human T-lymphotropic virus type 1 (HTLV-1) virus belongs to reterovisuses and is invovled in the etiology of adult T-lymphocytic leukemia (ATL) and tropical spastic paraparesis (TSP). This virus could be transmited through transfusion of contaminated blood or blood products, from the mother to the child or fetus, sexual intercourse, and sharing contaminated syringe needles among addicted individuals. There is no report regarding the prevalance of HTLV-1 among hemodialysis patietns in Tehran. Methods: In this descriptive study, 150 patients, who were under hemodialysis from four military hospitals of Tehran were included. Serum samples were screened to measure the titer of HTLV-1 antibodies by Dia-Pro ELISA kits. Enzyme linked immunosorbent assay (ELISA) positive samples were checked by the western blot method. Results: The results indicated that age of the patients was in the range of 24 to 88 years old and the mean age of patients was 63.58 +/- 13.41 years. Among all patients, only one patient (0.66%) had positive anti HTLV-1 ELISA test in the serum while other patients (99.4%) had negative results. The positive sample was confirmed by Western blot analysis. Conclusions: The prevalence rate of HTLV-1 among hemodialysis patients was not high in Tehran. However, it is necessary to take preventive measures to reduce its spread, especially through infectious hemodialysis machines.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Human T-lymphotropic virus type 1 (HTLV-1)
    Lefrère, JJ
    [J]. PRESSE MEDICALE, 2000, 29 (20): : 1134 - 1138
  • [2] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Santos, Rilma F. S.
    Conceicao, Gildasio C.
    Martins, Marcia S.
    Kraychete, Angiolina
    Penalva, Maria A. C.
    Carvalho, Edgar M.
    Lopes, Antonio Alberto
    Rocha, Paulo Novis
    [J]. BMC NEPHROLOGY, 2017, 18
  • [3] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Rilma F. S. Santos
    Gildásio C. Conceição
    Márcia S. Martins
    Angiolina Kraychete
    Maria A. C. Penalva
    Edgar M. Carvalho
    Antonio Alberto Lopes
    Paulo Novis Rocha
    [J]. BMC Nephrology, 18
  • [4] Prevalence of Human T-lymphotropic Virus Type 1 (HTLV-1) Infection in Patients with Different Etiologies
    Ghaffari, Javad
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (06) : 353 - 353
  • [5] Human T-lymphotropic virus type 1 (HTLV-1): Persistence and immune control
    Bangham, CRM
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 297 - 303
  • [6] DETECTION OF ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1)
    FANG, CT
    WILLIAMS, AE
    SANDLER, SG
    SLAMON, DJ
    POIESZ, BJ
    [J]. TRANSFUSION, 1988, 28 (02) : 179 - 183
  • [7] Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
    Charles R. M. Bangham
    [J]. International Journal of Hematology, 2003, 78 : 297 - 303
  • [8] Prevalence of Human T-lymphotropic Virus Type 1 (HTLV-1) Infection in Different Geographical Locations Reply
    Jalaeikhoo, Hasan
    Naghoosi, Hamed
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (06) : 354 - 354
  • [9] Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation
    Michael D Lairmore
    Lee Silverman
    Lee Ratner
    [J]. Oncogene, 2005, 24 : 6005 - 6015
  • [10] Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation
    Lairmore, MD
    Silverman, L
    Ratner, L
    [J]. ONCOGENE, 2005, 24 (39) : 6005 - 6015